{"altmetric_id":4263325,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":3},"twitter":{"unique_users_count":3,"unique_users":["articlesaboutip","BiosimilarIP","zumanor"],"posts_count":3}},"citation":{"altmetric_jid":"4f6fa6283cf058f610007ce6","authors":["Sebastian Moore","Grace Pead"],"doi":"10.1093\/jiplp\/jpv119","first_seen_on":"2015-07-11T02:00:50+00:00","issns":["1747-1540"],"journal":"Journal of Intellectual Property Law & Practice","last_mentioned_on":1441954139,"links":["http:\/\/jiplp.oxfordjournals.org\/content\/early\/2015\/07\/09\/jiplp.jpv119.short?rss=1","http:\/\/jiplp.oxfordjournals.org\/content\/10\/9\/653.short?rss=1"],"pdf_url":"http:\/\/jiplp.oxfordjournals.org\/content\/early\/2015\/07\/09\/jiplp.jpv119.full.pdf","publisher_subjects":[{"name":"Law","scheme":"era"}],"title":"Broad claim construction leads to invalidity of Novartis's patent for EXELON Alzheimer's patch","type":"article"},"altmetric_score":{"score":2.35,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.35},"context_for_score":{"all":{"total_number_of_other_articles":6326194,"mean":5.8273420893101,"rank":2208328,"this_scored_higher_than_pct":64,"this_scored_higher_than":4082500,"rank_type":"exact","sample_size":6326194,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":191453,"mean":8.5268601738295,"rank":70124,"this_scored_higher_than_pct":62,"this_scored_higher_than":119741,"rank_type":"exact","sample_size":191453,"percentile":62},"this_journal":{"total_number_of_other_articles":655,"mean":1.4571743119266,"rank":110,"this_scored_higher_than_pct":82,"this_scored_higher_than":538,"rank_type":"exact","sample_size":655,"percentile":82},"similar_age_this_journal_3m":{"total_number_of_other_articles":17,"mean":2.140625,"rank":6,"this_scored_higher_than_pct":64,"this_scored_higher_than":11,"rank_type":"exact","sample_size":17,"percentile":64}}},"demographics":{"poster_types":{"member_of_the_public":3},"users":{"twitter":{"cohorts":{"Members of the public":3}}},"geo":{"twitter":{"IN":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/articlesaboutip\/status\/619687481177415680","license":"datasift","citation_ids":[4263325],"posted_on":"2015-07-11T01:59:43+00:00","author":{"name":"Articles About IP","image":"https:\/\/pbs.twimg.com\/profile_images\/61653990\/idea_normal.jpg","description":"Interesting and useful articles relating to Intellectual Property. KEYWORDS: patents - trade marks - trademarks - designs - copyright - databases.","id_on_source":"articlesaboutip","tweeter_id":"15106552","geo":{"lt":null,"ln":null},"followers":47},"tweet_id":"619687481177415680"},{"url":"http:\/\/twitter.com\/BiosimilarIP\/statuses\/642227363292426241","license":"gnip","citation_ids":[4263325],"posted_on":"2015-09-11T06:45:10+00:00","author":{"name":"Pushpak Singh","url":"https:\/\/in.linkedin.com\/in\/questelindia","image":"https:\/\/pbs.twimg.com\/profile_images\/759676657993220102\/-zd8oI3g_normal.jpg","description":"Questel India Orbit Consultant #IPTrainer, Govt. Indian #Trademark #Patent #biosimilar Agent #PCT #WIPO #Search pushpak@scienceinfoware.com  +91-9867711779","id_on_source":"BiosimilarIP","tweeter_id":"832449764","geo":{"lt":19.07283,"ln":72.88261,"country":"IN"},"followers":1252},"tweet_id":"642227363292426241"},{"url":"http:\/\/twitter.com\/zumanor\/statuses\/642228324551557120","license":"gnip","rt":["BiosimilarIP"],"citation_ids":[4263325],"posted_on":"2015-09-11T06:48:59+00:00","author":{"name":"zuma","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"zumanor","tweeter_id":"500020201","geo":{"lt":null,"ln":null},"followers":80},"tweet_id":"642228324551557120"}]}}